Evidence map›Paper›PMID 35572968›Full record

ArticleFrontiers in medicine2022

Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning.

Rubén Queiro, Daniel Seoane-Mato, Ana Laiz, Eva Galindez Agirregoikoa, Carlos Montilla, Hye Sang Park, Jose A Pinto Tasende, Juan José Bethencourt Baute, Beatriz Joven Ibáñez, Elide Toniolo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 11 institutions in 1 country.

Rubén QueiroFaculty of Medicine, Rheumatology Service & the Principality of Asturias Institute for Health Research (ISPA), Universidad de Oviedo, Oviedo, Spain.
Daniel Seoane-MatoResearch Unit, Spanish Society of Rheumatology, Madrid, Spain.
Ana LaizRheumatology and Autoimmune Disease Department, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain.
Eva Galindez AgirregoikoaRheumatology Service, Hospital Universitario Basurto, Bilbao, Spain.
Carlos MontillaRheumatology Service, Hospital Universitario de Salamanca, Salamanca, Spain.
Hye Sang ParkRheumatology and Autoimmune Disease Department, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain.
Jose A Pinto TasendeRheumatology Service-INIBIC, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain.
Juan José Bethencourt BauteRheumatology Service, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
Beatriz Joven IbáñezRheumatology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.
Elide TonioloRheumatology Service, Hospital Universitari Son Llàtzer, Palma, Spain.
Julio RamírezArthritis Unit, Rheumatology Department, Hospital Clínic Barcelona, Barcelona, Spain.
Cristina Pruenza García-HinojosaKnowledge Engineering Institute, Universidad Autónoma de Madrid, Madrid, Spain.
Hospital de Sant Pau · ESComplejo Hospitalario de Salamanca · ESHospital Clínic de Barcelona · ESHospital de Basurto · ESHospital Son Llatzer · ESHospital Universitario 12 De Octubre · ESHospital Universitario de Canarias · ESInstituto de Investigación Biomédica de A Coruña · ESSpanish Society of Hematology and Hemotherapy · ESUniversidad Autónoma de Madrid · ESUniversidad de Oviedo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To identify patient- and disease-related characteristics that make it possible to predict higher disease severity in recent-onset PsA. Methods: We performed a multicenter observational prospective study (2-year follow-up, regular annual visits). The study population comprised patients aged ≥ 18 years who fulfilled the CASPAR criteria and less than 2 years since the onset of symptoms. Severe disease was defined at each visit as fulfillment of at least 1 of the following criteria: need for systemic treatment, Health Assessment Questionnaire (HAQ) > 0.5, polyarthritis. The dataset contained data for the independent variables from the baseline visit and follow-up visit number 1. These were matched with the outcome measures from follow-up visits 1 and 2, respectively. We trained a logistic regression model and random forest-type and XGBoost machine learning algorithms to analyze the association between the outcome measure and the variables selected in the bivariate analysis. Results: The sample comprised 158 patients. At the first follow-up visit, 78.2% of the patients who attended the clinic had severe disease. This percentage decreased to 76.4% at the second visit. The variables predicting severe disease were patient global pain, treatment with synthetic DMARDs, clinical form at diagnosis, high CRP, arterial hypertension, and psoriasis affecting the gluteal cleft and/or perianal area. The mean values of the measures of validity of the machine learning algorithms were all ≥ 80%. Conclusion: Our prediction model of severe disease advocates rigorous control of pain and inflammation, also addressing cardiometabolic comorbidities, in addition to actively searching for hidden psoriasis.

Indexed as

global painmachine learningperianal psoriasisprediction modelrecent-onset psoriatic arthritissevere disease

Identifiers

PMID35572968
PMCPMC9097678
OpenAlexW4285742681

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.